Please Wait.....
Report
3D Bioprinting Market by Component (3D bioprinters (Microextrusion, Inkjet, Laser), Bioinks, Software, Consumable), Material (Hydrogels, ECM), Application(Research (Regenerative Medicine, 3D cell Culture), Clinical (Skin, Bone)) - Global Forecast to 2029
Market Report I 2024-05-17 I 454 Pages I MarketsandMarkets
The 3D bioprinting market is projected to reach USD 2.4 Billion by 2029 from USD 1.3 Billion in 2024, at a CAGR of 12.7% during the forecast period. The 3D bioprinting market is driven by several key factors, including increasing collaborations between public and private entities and significant investments in research and development and growing interest in regenerative medicine and stem cell research.
"The 3D bioprinters segment held the dominant share in the 3D bioprinting market."
Based on technology, the global 3D bioprinting market is segmented into 3D bioprinters, bioinks, software, and consumable. The 3D bioprinters is segmented into Microextrusion bioprinters, , inkjet 3D bioprinters, laser-assisted bioprinters, magnetic 3D bioprinters, stereolithography-based bioprinters, and other 3D bioprinters. The 3D bioprinters segment dominated the 3D bioprinting market in 2023. Advancements in 3D bioprinting technology and rising demand for organ transplants serves as driving factor in the 3D bioprinting market.
"Research application accounted for the largest share of the application in 2023."
Based on application, the 3D bioprinting market is segmented into research application and clinical application. The research application is further segmented into regenerative medicine, 3D cell culture and drug research Also, the clinical application is segmented into bone & cartilage, blood vessels, skin and other clinical applications. In 2023, Research segment dominated the 3D bioprinting market. Research segment is anticipated to grow at significant CAGR during the forecast period of 2024-2028 owing to various factors such as biopharmaceuticals firms ramping up their utilization of 3D bioprinting technology.
"Asia Pacific region is likely to grow at a faster pace in the 3D bioprinting market."
The 3D bioprinting market region is segmented into North America, Europe, Asia Pacific, Latin America, Middle East and the Africa. The Asia-Pacific region is poised to experience significant growth in the 3D bioprinting market due to several key factors such as increasing healthcare expenditure in countries like China, India, and Southeast Asian nations region benefits from a significant population base and domestic system manufacturing, driving increased partnerships and collaborations aimed at healthcare improvement. With a high level of R&D intensity, market players are actively expanding their presence in the region, complemented by a surge in stem cell research, further stimulate market growth.
The primary interviews conducted for this report can be categorized as follows:
- By Respondent: Supply Side- 70%, and Demand Side - 30%
- By Designation (Supply Side): Managers - 45%, CXOs & Directors - 30%, Executives- 25%
- By Region: North America -40%, Europe -25%, Asia-Pacific -20%, Latin America -10%, Middle East-and Africa -5%
List of Companies Profiled in the Report:
- BICO Group AB (Sweden)
- 3D Systems Inc. (US)
- Merck KGaA (Germany)
- Organovo Holdings Inc (US)
- Collplant Biotechnologies Ltd. (Israel)
- regenHU (Switzerland)
- Aspect Biosystem Ltd. (Canada)
- Advanced Solutions Life Sciences, llc (US)
- Cyfuse Biomedical K.K (Japan)
- Rokit Healthcare Inc (South Korea)
- Hangzhou Genofei Biotechnology Co., Ltd. (China)
- Foldink (Armenia)
- Brinter (US)
- 3D bioprinting solution (Russia).
- REGEMAT 3D, SL (Spain)
- ??ietis (France)
- Sunp Biotech (US)
- GeSim - Gesellschaft Fur Silizium-Mikrosysteme Mbh (Germany)
- Medprin (China)
- Voxcell Bioinnovation Inc. (Canada)
- Prodways (France)
- Inventia Life Science Pty Ltd (Australia)
- Upnano Gmbh (Austria)
- UPM (Finland)
- Tissuelabs (Switzerland)
Research Coverage:
This report provides a detailed picture of the vaccine market. It aims at estimating the size and future growth potential of the market across different segments such as the components, material, application, end-user and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall 3D bioprinting market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
- Analysis of key drivers (growing adoption of 3D bioprinting technology in the pharmaceutical and cosmetic industries, technological advancement in the 3D bioprinting , increasing number of public-private partnerships, rising investments in R&D and medical devices), opportunities (Rising demand for organ transplants and growing demand for regenerative medicine and stem cell research) and challenges (biocompatibility issues and rigorous sterilization protocols and ethical concerns related to the use of 3D bioprinted products) are influencing the growth of 3D bioprinting market.
- Product Development/Innovation: Detailed insights on newly launched products of the 3D bioprinting market.
- Market Development: Comprehensive information about lucrative markets - the report analyses the 3D bioprinting market across varied regions.
- Market Diversification: Exhaustive information about new services, untapped geographies, recent developments, and investments in the 3D bioprinting market..
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players include BICO Group AB (Sweden), 3D Systems Inc. (US), Merck KGaA (Germany), Organovo Holdings Inc (US), Collplant Biotechnologies Ltd (Israel), regenHU (Switzerland), Aspect Biosystem (Canada), Advanced Solutions Life Sciences, llc (US), Cyfuse Biomedical K.K (Japan), Rokit Healthcare (South Korea), Hangzhou Genofei Biotechnology Co., Ltd. (China), Foldink (Armenia), Brinter (US) and 3D bioprinting solution (Russia).
1 INTRODUCTION 37
1.1 STUDY OBJECTIVES 37
1.2 MARKET DEFINITION 37
1.2.1 INCLUSIONS AND EXCLUSIONS 38
1.3 STUDY SCOPE 38
1.3.1 SEGMENTS COVERED 38
FIGURE 1 3D BIOPRINTING MARKET: SEGMENTS COVERED 38
1.3.2 REGIONS COVERED 39
FIGURE 2 3D BIOPRINTING MARKET: REGIONS COVERED 39
1.3.3 YEARS CONSIDERED 39
1.3.4 CURRENCY CONSIDERED 40
1.4 RESEARCH LIMITATIONS 40
1.5 STAKEHOLDERS 40
1.6 SUMMARY OF CHANGES 41
1.6.1 RECESSION IMPACT 41
2 RESEARCH METHODOLOGY 42
2.1 RESEARCH DATA 42
FIGURE 3 RESEARCH DESIGN 42
2.1.1 SECONDARY DATA 43
2.1.2 PRIMARY DATA 44
2.1.2.1 Breakdown of primaries 44
FIGURE 4 BREAKDOWN OF PRIMARIES: 3D BIOPRINTING MARKET 44
2.2 MARKET SIZE ESTIMATION 45
FIGURE 5 3D BIOPRINTING MARKET SIZE ESTIMATION (SUPPLY SIDE ANALYSIS), 2023 45
FIGURE 6 MARKET SIZE ESTIMATION: COMPANY REVENUE ANALYSIS-BASED ESTIMATION, 2023 46
FIGURE 7 ILLUSTRATIVE EXAMPLE OF BICO GROUP AB: REVENUE SHARE ANALYSIS (2023) 46
2.2.1 INSIGHTS FROM PRIMARY EXPERTS 48
FIGURE 8 MARKET VALIDATION FROM PRIMARY SOURCES 48
2.2.2 MARKET SIZE ESTIMATION, BY SEGMENT 49
FIGURE 9 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 49
2.3 GROWTH RATE ASSUMPTIONS 50
2.3.1 CAGR PROJECTIONS 50
FIGURE 10 3D BIOPRINTING MARKET: CAGR PROJECTIONS, 2024-2029 50
2.3.2 IMPACT OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS 51
TABLE 1 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS 51
2.4 STUDY ASSUMPTIONS 51
2.5 MARKET BREAKDOWN AND DATA TRIANGULATION 52
FIGURE 11 DATA TRIANGULATION METHODOLOGY 52
2.6 RISK ANALYSIS 53
2.7 IMPACT OF ECONOMIC RECESSION ON 3D BIOPRINTING MARKET 53
3 EXECUTIVE SUMMARY 54
FIGURE 12 3D BIOPRINTING MARKET, BY COMPONENT 2024 VS. 2029 (USD MILLION) 54
FIGURE 13 3D BIOPRINTING MARKET, BY APPLICATION, BY TYPE, 2024 VS. 2029 (USD MILLION) 55
FIGURE 14 3D BIOPRINTING MARKET, BY MATERIAL, 2024 VS. 2029 (USD MILLION) 56
FIGURE 15 3D BIOPRINTING MARKET, BY END USER, 2024 VS. 2029 (USD MILLION) 57
FIGURE 16 GEOGRAPHICAL SNAPSHOT OF 3D BIOPRINTING MARKET 58
4 PREMIUM INSIGHTS 59
4.1 3D BIOPRINTING MARKET OVERVIEW 59
FIGURE 17 RISING DEMAND FOR ORGAN TRANSPLANTS TO DRIVE MARKET 59
4.2 NORTH AMERICA: 3D BIOPRINTING MARKET, BY COMPONENT AND COUNTRY (2023) 60
FIGURE 18 US AND 3D BIOPRINTERS ACCOUNTED FOR LARGEST MARKET SHARE IN 2023 60
4.3 3D BIOPRINTING MARKET, BY COMPONENT, 2024 VS. 2029 61
FIGURE 19 3D BIOPRINTERS TO DOMINATE MARKET DURING STUDY PERIOD 61
4.4 3D BIOPRINTING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 62
FIGURE 20 ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 62
5 MARKET OVERVIEW 63
5.1 INTRODUCTION 63
5.2 MARKET DYNAMICS 63
FIGURE 21 3D BIOPRINTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 63
5.2.1 DRIVERS 64
5.2.1.1 Growing adoption of 3D bioprinting in pharmaceutical and cosmetic industries 64
5.2.1.2 Technological advancements in 3D bioprinting 65
5.2.1.3 Increasing number of public-private partnerships 65
5.2.1.4 Rising investments in medical device R&D 66
5.2.2 RESTRAINTS 67
5.2.2.1 Risk of 3D bioprinting failures 67
5.2.2.2 High cost of 3D bioprinters and bioinks 68
5.2.3 OPPORTUNITIES 68
5.2.3.1 Rising demand for organ transplants 68
FIGURE 22 NUMBER OF ORGAN TRANSPLANTS IN US (2024) 69
5.2.3.2 Growing demand for regenerative medicine and stem cell research 69
5.2.4 CHALLENGES 70
5.2.4.1 Biocompatibility issues and rigorous sterilization protocols 70
5.2.4.2 Ethical concerns related to use of 3D-bioprinted products 71
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES 72
FIGURE 23 REVENUE SHIFT TOWARDS 3D BIOPRINTING COMPANIES 72
5.4 TECHNOLOGY ANALYSIS 72
5.4.1 KEY TECHNOLOGIES 72
5.4.1.1 Extrusion-based bioprinting 72
5.4.1.2 Inkjet-based bioprinting 73
5.4.1.3 Stereolithography bioprinting 73
5.4.2 COMPLEMENTARY TECHNOLOGIES 73
5.4.2.1 Microfluidics and microfabrication 73
5.4.2.2 Nanotechnology and nanomaterials 73
5.4.3 ADJACENT TECHNOLOGIES 74
5.4.3.1 3D scanning and imaging 74
5.4.3.2 Organ-on-a-chip 74
5.4.3.3 Organoids technology 74
5.5 PRICING ANALYSIS 74
5.5.1 AVERAGE SELLING PRICE OF COMPONENTS, BY REGION 75
TABLE 2 3D BIOPRINTING MARKET: AVERAGE SELLING PRICE OF COMPONENTS, BY REGION, 2021-2023 75
5.6 VALUE CHAIN ANALYSIS 76
FIGURE 24 3D BIOPRINTING MARKET: VALUE CHAIN ANALYSIS 76
5.7 SUPPLY CHAIN ANALYSIS 77
FIGURE 25 3D BIOPRINTING MARKET: SUPPLY CHAIN ANALYSIS 77
TABLE 3 3D BIOPRINTING MARKET: ROLE IN SUPPLY CHAIN 79
5.8 ECOSYSTEM ANALYSIS 80
FIGURE 26 3D BIOPRINTING MARKET: ECOSYSTEM MAP 80
5.8.1 3D BIOPRINTER VENDORS 81
TABLE 4 3D BIOPRINTER VENDORS: ROLE IN ECOSYSTEM 81
5.8.2 BIOINK VENDORS 81
TABLE 5 BIOINK VENDORS: ROLE IN ECOSYSTEM 81
5.8.3 END USERS 82
TABLE 6 END USERS: ROLE IN ECOSYSTEM 82
5.8.4 REGULATORY BODIES 82
TABLE 7 REGULATORY BODIES: ROLE IN ECOSYSTEM 82
5.9 PATENT ANALYSIS 83
5.9.1 METHODOLOGY 83
5.9.2 NUMBER OF PATENTS APPLIED AND GRANTED, BY DOCUMENT TYPE, 2014-2024 83
TABLE 8 NUMBER OF PATENTS APPLIED AND GRANTED, 2014-2024 83
5.9.3 INNOVATION AND PATENT APPLICATION 83
FIGURE 27 NUMBER OF PATENTS GRANTED ANNUALLY, 2014-2024 84
5.9.4 TOP TEN PLAYERS WITH HIGHEST NUMBER OF PATENT APPLICATIONS 84
FIGURE 28 TOP TEN PLAYERS WITH HIGHEST NUMBER OF PATENT APPLICATIONS, 2014-2024 84
FIGURE 29 REGIONAL ANALYSIS OF PATENTS GRANTED, 2014-2024 85
TABLE 9 3D BIOPRINTING MARKET: TOP 12 PATENT OWNERS IN US, 2014-2024 85
TABLE 10 PATENTS IN 3D BIOPRINTING MARKET, 2023 86
5.10 TRADE ANALYSIS 89
5.10.1 IMPORT DATA FOR INK-JET PRINTING MACHINES (HS CODE: 844351) 89
TABLE 11 IMPORT VOLUME FOR INK-JET PRINTING MACHINES (HS CODE: 844351), 2019-2023 (TONS) 89
5.10.2 EXPORT DATA FOR INK-JET PRINTING MACHINES (HS CODE: 844351) 89
TABLE 12 EXPORT VOLUME FOR INK-JET PRINTING MACHINES (HS CODE: 844351), 2019-2023 (TONS) 89
5.10.3 IMPORT DATA FOR PRINTERS, COPYING MACHINES, AND FACSIMILE MACHINES, WHETHER OR NOT COMBINED (HS CODE: 844339) 90
TABLE 13 IMPORT VOLUME FOR PRINTERS, COPYING MACHINES, AND FACSIMILE MACHINES, WHETHER OR NOT COMBINED (HS CODE: 844339), 2019-2023 (USD) 90
5.10.4 EXPORT DATA FOR PRINTERS, COPYING MACHINES, AND FACSIMILE MACHINES, WHETHER OR NOT COMBINED (HS CODE: 844339) 90
TABLE 14 EXPORT VOLUME FOR PRINTERS, COPYING MACHINES, AND FACSIMILE MACHINES, WHETHER OR NOT COMBINED (HS CODE-844339), 2019-2023 (USD) 90
5.11 KEY CONFERENCES AND EVENTS, 2024-2025 91
TABLE 15 3D BIOPRINTING MARKET: KEY CONFERENCES AND EVENTS 91
5.12 REGULATORY LANDSCAPE 92
5.12.1 CDRH REGULATIONS ON 3D BIOPRINTING 92
5.12.2 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 92
TABLE 16 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 92
TABLE 17 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 93
TABLE 18 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 94
TABLE 19 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 95
5.13 INVESTMENT AND FUNDING SCENARIO 96
5.14 PORTER'S FIVE FORCES ANALYSIS 97
FIGURE 30 3D BIOPRINTING MARKET: PORTER'S FIVE FORCES ANALYSIS 97
TABLE 20 3D BIOPRINTING MARKET: PORTER'S FIVE FORCES ANALYSIS 97
5.14.1 THREAT OF NEW ENTRANTS 98
5.14.2 THREAT OF SUBSTITUTES 98
5.14.3 BARGAINING POWER OF BUYERS 98
5.14.4 BARGAINING POWER OF SUPPLIERS 98
5.14.5 INTENSITY OF COMPETITIVE RIVALRY 98
5.15 KEY STAKEHOLDERS AND BUYING CRITERIA 98
5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS 99
TABLE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS 99
5.15.2 KEY BUYING CRITERIA 100
5.15.2.1 Key buying criteria for top three end users 100
TABLE 22 KEY BUYING CRITERIA FOR TOP THREE END USERS IN 3D BIOPRINTERS MARKET 100
6 3D BIOPRINTING MARKET, BY COMPONENT 102
6.1 INTRODUCTION 103
TABLE 23 3D BIOPRINTING MARKET, BY COMPONENT, 2022-2029 (USD MILLION) 103
6.2 3D BIOPRINTERS 103
TABLE 24 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022-2029 (USD MILLION) 104
TABLE 25 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY REGION, 2022-2029 (USD MILLION) 104
TABLE 26 NORTH AMERICA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY COUNTRY, 2022-2029 (USD MILLION) 105
TABLE 27 EUROPE: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY COUNTRY, 2022-2029 (USD MILLION) 105
TABLE 28 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY COUNTRY, 2022-2029 (USD MILLION) 106
TABLE 29 LATIN AMERICA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY COUNTRY, 2022-2029 (USD MILLION) 106
TABLE 30 MIDDLE EAST: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY COUNTRY, 2022-2029 (USD MILLION) 107
TABLE 31 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY COUNTRY, 2022-2029 (USD MILLION) 107
6.2.1 MICRO EXTRUSION BIOPRINTERS 107
6.2.1.1 Adaptability to different biomaterial types to fuel segment growth 107
TABLE 32 MICRO EXTRUSION BIOPRINTERS MARKET, BY REGION, 2022-2029 (USD MILLION) 108
TABLE 33 NORTH AMERICA: MICRO EXTRUSION BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 109
TABLE 34 EUROPE: MICRO EXTRUSION BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 109
TABLE 35 ASIA PACIFIC: MICRO EXTRUSION BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 110
TABLE 36 LATIN AMERICA: MICRO EXTRUSION BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 110
TABLE 37 MIDDLE EAST: MICRO EXTRUSION BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 111
TABLE 38 GCC COUNTRIES: MICRO EXTRUSION BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 111
6.2.2 INKJET 3D BIOPRINTERS 111
6.2.2.1 High cell viability and low cost to propel market growth 111
TABLE 39 INKJET 3D BIOPRINTERS MARKET, BY REGION, 2022-2029 (USD MILLION) 112
TABLE 40 NORTH AMERICA: INKJET 3D BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 112
TABLE 41 EUROPE: INKJET 3D BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 113
TABLE 42 ASIA PACIFIC: INKJET 3D BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 113
TABLE 43 LATIN AMERICA: INKJET 3D BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 114
TABLE 44 MIDDLE EAST: INKJET 3D BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 114
TABLE 45 GCC COUNTRIES: INKJET 3D BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 115
6.2.3 LASER-ASSISTED BIOPRINTERS 115
6.2.3.1 Higher resolution and better formation of 3D structures to augment segment growth 115
TABLE 46 LASER-ASSISTED BIOPRINTERS MARKET, BY REGION, 2022-2029 (USD MILLION) 116
TABLE 47 NORTH AMERICA: LASER-ASSISTED BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 116
TABLE 48 EUROPE: LASER-ASSISTED BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 117
TABLE 49 ASIA PACIFIC: LASER-ASSISTED BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 117
TABLE 50 LATIN AMERICA: LASER-ASSISTED BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 118
TABLE 51 MIDDLE EAST: LASER-ASSISTED BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 118
TABLE 52 GCC COUNTRIES: LASER-ASSISTED BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 119
6.2.4 STEREOLITHOGRAPHY-BASED BIOPRINTERS 119
6.2.4.1 Better printing quality, speed, and cell viability to aid growth 119
TABLE 53 STEREOLITHOGRAPHY-BASED BIOPRINTERS MARKET, BY REGION, 2022-2029 (USD MILLION) 120
TABLE 54 NORTH AMERICA: STEREOLITHOGRAPHY-BASED BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 120
TABLE 55 EUROPE: STEREOLITHOGRAPHY-BASED BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 121
TABLE 56 ASIA PACIFIC: STEREOLITHOGRAPHY-BASED BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 121
TABLE 57 LATIN AMERICA: STEREOLITHOGRAPHY-BASED BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 122
TABLE 58 MIDDLE EAST: STEREOLITHOGRAPHY-BASED BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 122
TABLE 59 GCC COUNTRIES: STEREOLITHOGRAPHY-BASED BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 123
6.2.5 MAGNETIC 3D BIOPRINTERS 123
6.2.5.1 Improved accuracy and speed in cultured tissue formation and processing to fuel segment growth 123
TABLE 60 MAGNETIC 3D BIOPRINTERS MARKET, BY REGION, 2022-2029 (USD MILLION) 124
TABLE 61 NORTH AMERICA: MAGNETIC 3D BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 124
TABLE 62 EUROPE: MAGNETIC 3D BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 125
TABLE 63 ASIA PACIFIC: MAGNETIC 3D BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 125
TABLE 64 LATIN AMERICA: MAGNETIC 3D BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 126
TABLE 65 MIDDLE EAST: MAGNETIC 3D BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 126
TABLE 66 GCC COUNTRIES: MAGNETIC 3D BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 127
6.2.6 OTHER 3D BIOPRINTERS 127
TABLE 67 OTHER 3D BIOPRINTERS MARKET, BY REGION, 2022-2029 (USD MILLION) 128
TABLE 68 NORTH AMERICA: OTHER 3D BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 128
TABLE 69 EUROPE: OTHER 3D BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 129
TABLE 70 ASIA PACIFIC: OTHER 3D BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 129
TABLE 71 LATIN AMERICA: OTHER 3D BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 130
TABLE 72 MIDDLE EAST: OTHER 3D BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 130
TABLE 73 GCC COUNTRIES: OTHER 3D BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 131
6.3 BIOINKS 131
TABLE 74 3D BIOPRINTERS MARKET FOR BIOINKS, BY TYPE, 2022-2029 (USD MILLION) 132
TABLE 75 3D BIOPRINTING MARKET FOR BIOINKS, BY REGION, 2022-2029 (USD MILLION) 132
TABLE 76 NORTH AMERICA: 3D BIOPRINTING MARKET FOR BIOINKS, BY COUNTRY, 2022-2029 (USD MILLION) 133
TABLE 77 EUROPE: 3D BIOPRINTING MARKET FOR BIOINKS, BY COUNTRY, 2022-2029 (USD MILLION) 133
TABLE 78 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR BIOINKS, BY COUNTRY, 2022-2029 (USD MILLION) 134
TABLE 79 LATIN AMERICA: 3D BIOPRINTING MARKET FOR BIOINKS, BY COUNTRY, 2022-2029 (USD MILLION) 134
TABLE 80 MIDDLE EAST: 3D BIOPRINTING MARKET FOR BIOINKS, BY COUNTRY, 2022-2029 (USD MILLION) 135
TABLE 81 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR BIOINKS, BY COUNTRY, 2022-2029 (USD MILLION) 135
6.3.1 NATURAL BIOINKS 136
6.3.1.1 Increasing investment in R&D and product developments to drive market 136
TABLE 82 NATURAL BIOINKS MARKET, BY REGION, 2022-2029 (USD MILLION) 136
TABLE 83 NORTH AMERICA: NATURAL BIOINKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 137
TABLE 84 EUROPE: NATURAL BIOINKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 137
TABLE 85 ASIA PACIFIC: NATURAL BIOINKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 138
TABLE 86 LATIN AMERICA: NATURAL BIOINKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 138
TABLE 87 MIDDLE EAST: NATURAL BIOINKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 139
TABLE 88 GCC COUNTRIES: NATURAL BIOINKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 139
6.3.2 HYBRID BIOINKS 139
6.3.2.1 Higher mechanical strength and greater biocompatibility to boost segment growth 139
TABLE 89 HYBRID BIOINKS MARKET, BY REGION, 2022-2029 (USD MILLION) 140
TABLE 90 NORTH AMERICA: HYBRID BIOINKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 140
TABLE 91 EUROPE: HYBRID BIOINKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 141
TABLE 92 ASIA PACIFIC: HYBRID BIOINKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 141
TABLE 93 LATIN AMERICA: HYBRID BIOINKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 142
TABLE 94 MIDDLE EAST: HYBRID BIOINKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 142
TABLE 95 GCC COUNTRIES: HYBRID BIOINKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 143
6.3.3 SYNTHETIC BIOINKS 143
6.3.3.1 Flexibility, control, and consistency to aid segment growth 143
TABLE 96 SYNTHETIC BIOINKS MARKET, BY REGION, 2022-2029 (USD MILLION) 144
TABLE 97 NORTH AMERICA: SYNTHETIC BIOINKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 144
TABLE 98 EUROPE: SYNTHETIC BIOINKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 145
TABLE 99 ASIA PACIFIC: SYNTHETIC BIOINKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 145
TABLE 100 LATIN AMERICA: SYNTHETIC BIOINKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 146
TABLE 101 MIDDLE EAST: SYNTHETIC BIOINKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 146
TABLE 102 GCC COUNTRIES: SYNTHETIC BIOINKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 147
6.4 SOFTWARE 147
6.4.1 INCREASING INNOVATIONS AND ADVANCEMENTS TO PROPEL SEGMENT GROWTH 147
TABLE 103 3D BIOPRINTING MARKET FOR SOFTWARE, BY REGION, 2022-2029 (USD MILLION) 148
TABLE 104 NORTH AMERICA: 3D BIOPRINTING MARKET FOR SOFTWARE, BY COUNTRY, 2022-2029 (USD MILLION) 148
TABLE 105 EUROPE: 3D BIOPRINTING MARKET FOR SOFTWARE, BY COUNTRY, 2022-2029 (USD MILLION) 149
TABLE 106 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR SOFTWARE, BY COUNTRY, 2022-2029 (USD MILLION) 149
TABLE 107 LATIN AMERICA: 3D BIOPRINTING MARKET FOR SOFTWARE, BY COUNTRY, 2022-2029 (USD MILLION) 150
TABLE 108 MIDDLE EAST: 3D BIOPRINTING MARKET FOR SOFTWARE, BY COUNTRY, 2022-2029 (USD MILLION) 150
TABLE 109 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR SOFTWARE, BY COUNTRY, 2022-2029 (USD MILLION) 151
6.5 CONSUMABLES 151
6.5.1 NEED FOR PRECISE BIOINK DEPOSITION FOR INTRICATE TISSUE STRUCTURES TO DRIVE MARKET 151
TABLE 110 3D BIOPRINTING MARKET FOR CONSUMABLES, BY REGION, 2022-2029 (USD MILLION) 152
TABLE 111 NORTH AMERICA: 3D BIOPRINTING MARKET FOR CONSUMABLES, BY COUNTRY, 2022-2029 (USD MILLION) 152
TABLE 112 EUROPE: 3D BIOPRINTING MARKET FOR CONSUMABLES, BY COUNTRY, 2022-2029 (USD MILLION) 153
TABLE 113 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR CONSUMABLES, BY COUNTRY, 2022-2029 (USD MILLION) 153
TABLE 114 LATIN AMERICA: 3D BIOPRINTING MARKET FOR CONSUMABLES, BY COUNTRY, 2022-2029 (USD MILLION) 154
TABLE 115 MIDDLE EAST: 3D BIOPRINTING MARKET FOR CONSUMABLES, BY COUNTRY, 2022-2029 (USD MILLION) 154
TABLE 116 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR CONSUMABLES, BY COUNTRY, 2022-2029 (USD MILLION) 155
7 3D BIOPRINTING MARKET, BY MATERIAL 156
7.1 INTRODUCTION 157
TABLE 117 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2029 (USD MILLION) 157
7.2 LIVING CELLS 157
7.2.1 INCREASED VIABILITY AND TECHNOLOGICAL ADVANCEMENTS TO AUGMENT MARKET GROWTH 157
TABLE 118 3D BIOPRINTING MARKET FOR LIVING CELLS, BY REGION, 2022-2029 (USD MILLION) 158
TABLE 119 NORTH AMERICA: 3D BIOPRINTING MARKET FOR LIVING CELLS, BY COUNTRY, 2022-2029 (USD MILLION) 159
TABLE 120 EUROPE: 3D BIOPRINTING MARKET FOR LIVING CELLS, BY COUNTRY, 2022-2029 (USD MILLION) 159
TABLE 121 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR LIVING CELLS, BY COUNTRY, 2022-2029 (USD MILLION) 160
TABLE 122 LATIN AMERICA: 3D BIOPRINTING MARKET FOR LIVING CELLS, BY COUNTRY, 2022-2029 (USD MILLION) 160
TABLE 123 MIDDLE EAST: 3D BIOPRINTING MARKET FOR LIVING CELLS, BY COUNTRY, 2022-2029 (USD MILLION) 161
TABLE 124 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR LIVING CELLS, BY COUNTRY, 2022-2029 (USD MILLION) 161
7.3 HYDROGELS 161
7.3.1 INCREASING INVESTMENTS AND FUNDING TO BOOST MARKET GROWTH 161
TABLE 125 3D BIOPRINTING MARKET FOR HYDROGELS, BY REGION, 2022-2029 (USD MILLION) 162
TABLE 126 NORTH AMERICA: 3D BIOPRINTING MARKET FOR HYDROGELS, BY COUNTRY, 2022-2029 (USD MILLION) 163
TABLE 127 EUROPE: 3D BIOPRINTING MARKET FOR HYDROGELS, BY COUNTRY, 2022-2029 (USD MILLION) 163
TABLE 128 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR HYDROGELS, BY COUNTRY, 2022-2029 (USD MILLION) 164
TABLE 129 LATIN AMERICA: 3D BIOPRINTING MARKET FOR HYDROGELS, BY COUNTRY, 2022-2029 (USD MILLION) 164
TABLE 130 MIDDLE EAST: 3D BIOPRINTING MARKET FOR HYDROGELS, BY COUNTRY, 2022-2029 (USD MILLION) 165
TABLE 131 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR HYDROGELS, BY COUNTRY, 2022-2029 (USD MILLION) 165
7.4 EXTRACELLULAR MATRICES 165
7.4.1 INCREASED FOCUS ON R&D AND ADVANCEMENTS IN TISSUE ENGINEERING TO SUPPORT MARKET GROWTH 165
TABLE 132 3D BIOPRINTING MARKET FOR EXTRACELLULAR MATRICES, BY REGION, 2022-2029 (USD MILLION) 166
TABLE 133 NORTH AMERICA: 3D BIOPRINTING MARKET FOR EXTRACELLULAR MATRICES, BY COUNTRY, 2022-2029 (USD MILLION) 167
TABLE 134 EUROPE: 3D BIOPRINTING MARKET FOR EXTRACELLULAR MATRICES, BY COUNTRY, 2022-2029 (USD MILLION) 167
TABLE 135 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR EXTRACELLULAR MATRICES, BY COUNTRY, 2022-2029 (USD MILLION) 168
TABLE 136 LATIN AMERICA: 3D BIOPRINTING MARKET FOR EXTRACELLULAR MATRICES, BY COUNTRY, 2022-2029 (USD MILLION) 168
TABLE 137 MIDDLE EAST: 3D BIOPRINTING MARKET FOR EXTRACELLULAR MATRICES, BY COUNTRY, 2022-2029 (USD MILLION) 169
TABLE 138 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR EXTRACELLULAR MATRICES, BY COUNTRY, 2022-2029 (USD MILLION) 169
7.5 OTHER MATERIALS 170
TABLE 139 3D BIOPRINTING MARKET FOR OTHER MATERIALS, BY REGION, 2022-2029 (USD MILLION) 171
TABLE 140 NORTH AMERICA: 3D BIOPRINTING MARKET FOR OTHER MATERIALS, BY COUNTRY, 2022-2029 (USD MILLION) 171
TABLE 141 EUROPE: 3D BIOPRINTING MARKET FOR OTHER MATERIALS, BY COUNTRY, 2022-2029 (USD MILLION) 172
TABLE 142 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR OTHER MATERIALS, BY COUNTRY, 2022-2029 (USD MILLION) 172
TABLE 143 LATIN AMERICA: 3D BIOPRINTING MARKET FOR OTHER MATERIALS, BY COUNTRY, 2022-2029 (USD MILLION) 173
TABLE 144 MIDDLE EAST: 3D BIOPRINTING MARKET FOR OTHER MATERIALS, BY COUNTRY, 2022-2029 (USD MILLION) 173
TABLE 145 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR OTHER MATERIALS, BY COUNTRY, 2022-2029 (USD MILLION) 174
8 3D BIOPRINTING MARKET, BY APPLICATION 175
8.1 INTRODUCTION 176
TABLE 146 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 176
8.2 RESEARCH APPLICATIONS 176
TABLE 147 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 177
TABLE 148 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2022-2029 (USD MILLION) 177
TABLE 149 NORTH AMERICA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 178
TABLE 150 EUROPE: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 178
TABLE 151 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 179
TABLE 152 LATIN AMERICA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 179
TABLE 153 MIDDLE EAST: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 180
TABLE 154 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 180
8.2.1 DRUG RESEARCH 180
8.2.1.1 Better precision and greater customization facilities in pharmaceutical sector to drive segment 180
TABLE 155 DRUG RESEARCH MARKET, BY REGION, 2022-2029 (USD MILLION) 182
TABLE 156 NORTH AMERICA: DRUG RESEARCH MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 182
TABLE 157 EUROPE: DRUG RESEARCH MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 183
TABLE 158 ASIA PACIFIC: DRUG RESEARCH MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 183
TABLE 159 LATIN AMERICA: DRUG RESEARCH MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 184
TABLE 160 MIDDLE EAST: DRUG RESEARCH MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 184
TABLE 161 GCC COUNTRIES: DRUG RESEARCH MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 184
8.2.2 REGENERATIVE MEDICINE 185
8.2.2.1 Growing demand for organ transplants to support segment growth 185
TABLE 162 REGENERATIVE MEDICINE MARKET, BY REGION, 2022-2029 (USD MILLION) 186
TABLE 163 NORTH AMERICA: REGENERATIVE MEDICINE MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 186
TABLE 164 EUROPE: REGENERATIVE MEDICINE MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 187
TABLE 165 ASIA PACIFIC: REGENERATIVE MEDICINE MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 187
TABLE 166 LATIN AMERICA: REGENERATIVE MEDICINE MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 188
TABLE 167 MIDDLE EAST: REGENERATIVE MEDICINE MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 188
TABLE 168 GCC COUNTRIES: REGENERATIVE MEDICINE MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 189
8.2.3 3D CELL CULTURE 189
8.2.3.1 Rising investments in cell culture development to augment segment growth 189
TABLE 169 3D CELL CULTURE MARKET, BY REGION, 2022-2029 (USD MILLION) 190
TABLE 170 NORTH AMERICA: 3D CELL CULTURE MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 190
TABLE 171 EUROPE: 3D CELL CULTURE MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 191
TABLE 172 ASIA PACIFIC: 3D CELL CULTURE MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 191
TABLE 173 LATIN AMERICA: 3D CELL CULTURE MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 192
TABLE 174 MIDDLE EAST: 3D CELL CULTURE MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 192
TABLE 175 GCC COUNTRIES: 3D CELL CULTURE MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 192
8.3 CLINICAL APPLICATIONS 193
TABLE 176 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 193
TABLE 177 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2022-2029 (USD MILLION) 194
TABLE 178 NORTH AMERICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 194
TABLE 179 EUROPE: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 195
TABLE 180 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 195
TABLE 181 LATIN AMERICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 196
TABLE 182 MIDDLE EAST: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 196
TABLE 183 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 197
8.3.1 SKIN 197
8.3.1.1 Rising applications in skincare and cosmetics to propel segment growth 197
TABLE 184 SKIN MARKET, BY REGION, 2022-2029 (USD MILLION) 198
TABLE 185 NORTH AMERICA: SKIN MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 198
TABLE 186 EUROPE: SKIN MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 199
TABLE 187 ASIA PACIFIC: SKIN MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 199
TABLE 188 LATIN AMERICA: SKIN MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 200
TABLE 189 MIDDLE EAST: SKIN MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 200
TABLE 190 GCC COUNTRIES: SKIN MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 200
8.3.2 BONE & CARTILAGE 201
8.3.2.1 Increasing incidence of musculoskeletal conditions to support segment growth 201
TABLE 191 BONE & CARTILAGE MARKET, BY REGION, 2022-2029 (USD MILLION) 202
TABLE 192 NORTH AMERICA: BONE & CARTILAGE MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 202
TABLE 193 EUROPE: BONE & CARTILAGE MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 203
TABLE 194 ASIA PACIFIC: BONE & CARTILAGE MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 203
TABLE 195 LATIN AMERICA: BONE & CARTILAGE MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 204
TABLE 196 MIDDLE EAST: BONE & CARTILAGE MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 204
TABLE 197 GCC COUNTRIES: BONE & CARTILAGE MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 204
8.3.3 BLOOD VESSELS 205
8.3.3.1 Growing focus on research activities to aid segment growth 205
TABLE 198 BLOOD VESSELS MARKET, BY REGION, 2022-2029 (USD MILLION) 205
TABLE 199 NORTH AMERICA: BLOOD VESSELS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 206
TABLE 200 EUROPE: BLOOD VESSELS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 206
TABLE 201 ASIA PACIFIC: BLOOD VESSELS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 207
TABLE 202 LATIN AMERICA: BLOOD VESSELS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 207
TABLE 203 MIDDLE EAST: BLOOD VESSELS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 208
TABLE 204 GCC COUNTRIES: BLOOD VESSELS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 208
8.3.4 OTHER CLINICAL APPLICATIONS 208
TABLE 205 OTHER CLINICAL APPLICATIONS MARKET, BY REGION, 2022-2029 (USD MILLION) 209
TABLE 206 NORTH AMERICA: OTHER CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 210
TABLE 207 EUROPE: OTHER CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 210
TABLE 208 ASIA PACIFIC: OTHER CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 211
TABLE 209 LATIN AMERICA: OTHER CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 211
TABLE 210 MIDDLE EAST: OTHER CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 212
TABLE 211 GCC COUNTRIES: OTHER CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 212
9 3D BIOPRINTING MARKET, BY END USER 213
9.1 INTRODUCTION 214
TABLE 212 3D BIOPRINTING MARKET, BY END USER, 2022-2029 (USD MILLION) 214
9.2 ACADEMIC & RESEARCH INSTITUTES 214
9.2.1 RISING GOVERNMENT FUNDING AND INCREASING NUMBER OF INDUSTRY-ACADEMIA COLLABORATIONS TO DRIVE MARKET 214
TABLE 213 3D BIOPRINTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION) 215
TABLE 214 NORTH AMERICA: 3D BIOPRINTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION) 216
TABLE 215 EUROPE: 3D BIOPRINTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION) 216
TABLE 216 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION) 217
TABLE 217 LATIN AMERICA: 3D BIOPRINTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION) 217
TABLE 218 MIDDLE EAST: 3D BIOPRINTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION) 218
TABLE 219 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION) 218
9.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 219
9.3.1 INCREASING PREVALENCE OF CHRONIC DISEASES TO PROPEL MARKET GROWTH 219
TABLE 220 3D BIOPRINTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION) 220
TABLE 221 NORTH AMERICA: 3D BIOPRINTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION) 220
TABLE 222 EUROPE: 3D BIOPRINTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION) 221
TABLE 223 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION) 221
TABLE 224 LATIN AMERICA: 3D BIOPRINTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION) 222
TABLE 225 MIDDLE EAST: 3D BIOPRINTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION) 222
TABLE 226 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION) 223
9.4 HOSPITALS 223
9.4.1 RISING NUMBER OF STRATEGIC PARTNERSHIPS WITH BIOTECHNOLOGY COMPANIES TO AID MARKET GROWTH 223
TABLE 227 3D BIOPRINTING MARKET FOR HOSPITALS, BY REGION, 2022-2029 (USD MILLION) 224
TABLE 228 NORTH AMERICA: 3D BIOPRINTING MARKET FOR HOSPITALS, BY COUNTRY, 2022-2029 (USD MILLION) 224
TABLE 229 EUROPE: 3D BIOPRINTING MARKET FOR HOSPITALS, BY COUNTRY, 2022-2029 (USD MILLION) 225
TABLE 230 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR HOSPITALS, BY COUNTRY, 2022-2029 (USD MILLION) 225
TABLE 231 LATIN AMERICA: 3D BIOPRINTING MARKET FOR HOSPITALS, BY COUNTRY, 2022-2029 (USD MILLION) 226
TABLE 232 MIDDLE EAST: 3D BIOPRINTING MARKET FOR HOSPITALS, BY COUNTRY, 2022-2029 (USD MILLION) 226
TABLE 233 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR HOSPITALS, BY COUNTRY, 2022-2029 (USD MILLION) 227
10 3D BIOPRINTING MARKET, BY REGION 228
10.1 INTRODUCTION 229
TABLE 234 3D BIOPRINTING MARKET, BY REGION, 2022-2029 (USD MILLION) 229
10.2 NORTH AMERICA 230
FIGURE 31 NORTH AMERICA: 3D BIOPRINTING MARKET SNAPSHOT 230
TABLE 235 NORTH AMERICA: 3D BIOPRINTING MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 231
TABLE 236 NORTH AMERICA: 3D BIOPRINTING MARKET, BY COMPONENT, 2022-2029 (USD MILLION) 231
TABLE 237 NORTH AMERICA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022-2029 (USD MILLION) 232
TABLE 238 NORTH AMERICA: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022-2029 (USD MILLION) 232
TABLE 239 NORTH AMERICA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2029 (USD MILLION) 233
TABLE 240 NORTH AMERICA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 233
TABLE 241 NORTH AMERICA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 234
TABLE 242 NORTH AMERICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 234
TABLE 243 NORTH AMERICA: 3D BIOPRINTING MARKET, BY END USER, 2022-2029 (USD MILLION) 235
10.2.1 NORTH AMERICA: RECESSION IMPACT 235
10.2.2 US 235
10.2.2.1 US to dominate North American 3D bioprinting market during forecast period 235
TABLE 244 US: 3D BIOPRINTING MARKET, BY COMPONENT, 2022-2029 (USD MILLION) 237
TABLE 245 US: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022-2029 (USD MILLION) 237
TABLE 246 US: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022-2029 (USD MILLION) 238
TABLE 247 US: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2029 (USD MILLION) 238
TABLE 248 US: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 239
TABLE 249 US: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 239
TABLE 250 US: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 240
TABLE 251 US: 3D BIOPRINTING MARKET, BY END USER, 2022-2029 (USD MILLION) 240
10.2.3 CANADA 241
10.2.3.1 Increased number of public-private partnerships for life science research to drive market 241
TABLE 252 CANADA: 3D BIOPRINTING MARKET, BY COMPONENT, 2022-2029 (USD MILLION) 241
TABLE 253 CANADA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022-2029 (USD MILLION) 242
TABLE 254 CANADA: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022-2029 (USD MILLION) 242
TABLE 255 CANADA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2029 (USD MILLION) 243
TABLE 256 CANADA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 243
TABLE 257 CANADA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 244
TABLE 258 CANADA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 244
TABLE 259 CANADA: 3D BIOPRINTING MARKET, BY END USER, 2022-2029 (USD MILLION) 245
10.3 EUROPE 245
TABLE 260 EUROPE: 3D BIOPRINTING MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 246
TABLE 261 EUROPE: 3D BIOPRINTING MARKET, BY COMPONENT, 2022-2029 (USD MILLION) 246
TABLE 262 EUROPE: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022-2029 (USD MILLION) 247
TABLE 263 EUROPE: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022-2029 (USD MILLION) 247
TABLE 264 EUROPE: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2029 (USD MILLION) 248
TABLE 265 EUROPE: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 248
TABLE 266 EUROPE: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 249
TABLE 267 EUROPE: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 249
TABLE 268 EUROPE: 3D BIOPRINTING MARKET, BY END USER, 2022-2029 (USD MILLION) 250
10.3.1 EUROPE: RECESSION IMPACT 250
10.3.2 GERMANY 250
10.3.2.1 Rising healthcare expenditure and increasing demand for organ transplants to favor market growth 250
TABLE 269 GERMANY: 3D BIOPRINTING MARKET, BY COMPONENT, 2022-2029 (USD MILLION) 251
TABLE 270 GERMANY: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022-2029 (USD MILLION) 252
TABLE 271 GERMANY: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022-2029 (USD MILLION) 252
TABLE 272 GERMANY: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2029 (USD MILLION) 253
TABLE 273 GERMANY: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 253
TABLE 274 GERMANY: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 254
TABLE 275 GERMANY: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 254
TABLE 276 GERMANY: 3D BIOPRINTING MARKET, BY END USER, 2022-2029 (USD MILLION) 255
10.3.3 UK 255
10.3.3.1 Rising prevalence of chronic diseases and increasing R&D activities to drive market 255
TABLE 277 UK: 3D BIOPRINTING MARKET, BY COMPONENT, 2022-2029 (USD MILLION) 256
TABLE 278 UK: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022-2029 (USD MILLION) 256
TABLE 279 UK: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022-2029 (USD MILLION) 257
TABLE 280 UK: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2029 (USD MILLION) 257
TABLE 281 UK: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 258
TABLE 282 UK: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 258
TABLE 283 UK: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 259
TABLE 284 UK: 3D BIOPRINTING MARKET, BY END USER, 2022-2029 (USD MILLION) 259
10.3.4 FRANCE 259
10.3.4.1 Increasing availability of advanced medical technologies to support market growth 259
TABLE 285 FRANCE: 3D BIOPRINTING MARKET, BY COMPONENT, 2022-2029 (USD MILLION) 260
TABLE 286 FRANCE: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022-2029 (USD MILLION) 261
TABLE 287 FRANCE: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022-2029 (USD MILLION) 261
TABLE 288 FRANCE: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2029 (USD MILLION) 262
TABLE 289 FRANCE: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 262
TABLE 290 FRANCE: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 263
TABLE 291 FRANCE: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 263
TABLE 292 FRANCE: 3D BIOPRINTING MARKET, BY END USER, 2022-2029 (USD MILLION) 264
10.3.5 ITALY 264
10.3.5.1 Increased research investment and funding to support market growth 264
TABLE 293 ITALY: 3D BIOPRINTING MARKET, BY COMPONENT, 2022-2029 (USD MILLION) 265
TABLE 294 ITALY: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022-2029 (USD MILLION) 265
TABLE 295 ITALY: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022-2029 (USD MILLION) 266
TABLE 296 ITALY: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2029 (USD MILLION) 266
TABLE 297 ITALY: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 267
TABLE 298 ITALY: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 267
TABLE 299 ITALY: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 268
TABLE 300 ITALY: 3D BIOPRINTING MARKET, BY END USER, 2022-2029 (USD MILLION) 268
10.3.6 SPAIN 269
10.3.6.1 Favorable investment scenario and increase in number of research centers to aid market growth 269
TABLE 301 SPAIN: 3D BIOPRINTING MARKET, BY COMPONENT, 2022-2029 (USD MILLION) 269
TABLE 302 SPAIN: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022-2029 (USD MILLION) 270
TABLE 303 SPAIN: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022-2029 (USD MILLION) 270
TABLE 304 SPAIN: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2029 (USD MILLION) 271
TABLE 305 SPAIN: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 271
TABLE 306 SPAIN: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 272
TABLE 307 SPAIN: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 272
TABLE 308 SPAIN: 3D BIOPRINTING MARKET, BY END USER, 2022-2029 (USD MILLION) 273
10.3.7 REST OF EUROPE 273
TABLE 309 REST OF EUROPE: 3D BIOPRINTING MARKET, BY COMPONENT, 2022-2029 (USD MILLION) 274
TABLE 310 REST OF EUROPE: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022-2029 (USD MILLION) 274
TABLE 311 REST OF EUROPE: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022-2029 (USD MILLION) 275
TABLE 312 REST OF EUROPE: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2029 (USD MILLION) 275
TABLE 313 REST OF EUROPE: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 276
TABLE 314 REST OF EUROPE: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 276
TABLE 315 REST OF EUROPE: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 277
TABLE 316 REST OF EUROPE: 3D BIOPRINTING MARKET, BY END USER, 2022-2029 (USD MILLION) 277
10.4 ASIA PACIFIC 278
FIGURE 32 ASIA PACIFIC: 3D BIOPRINTING MARKET SNAPSHOT 279
TABLE 317 ASIA PACIFIC: 3D BIOPRINTING MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 280
TABLE 318 ASIA PACIFIC: 3D BIOPRINTING MARKET, BY COMPONENT, 2022-2029 (USD MILLION) 280
TABLE 319 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022-2029 (USD MILLION) 281
TABLE 320 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022-2029 (USD MILLION) 281
TABLE 321 ASIA PACIFIC: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2029 (USD MILLION) 282
TABLE 322 ASIA PACIFIC: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 282
TABLE 323 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 283
TABLE 324 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 283
TABLE 325 ASIA PACIFIC: 3D BIOPRINTING MARKET, BY END USER, 2022-2029 (USD MILLION) 284
10.4.1 CHINA 284
10.4.1.1 Increasing government focus on pharmaceutical R&D and growing demand for organ transplants to augment market growth 284
TABLE 326 CHINA: 3D BIOPRINTING MARKET, BY COMPONENT, 2022-2029 (USD MILLION) 285
TABLE 327 CHINA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022-2029 (USD MILLION) 285
TABLE 328 CHINA: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022-2029 (USD MILLION) 286
TABLE 329 CHINA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2029 (USD MILLION) 286
TABLE 330 CHINA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 287
TABLE 331 CHINA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 287
TABLE 332 CHINA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 288
TABLE 333 CHINA: 3D BIOPRINTING MARKET, BY END USER, 2022-2029 (USD MILLION) 288
10.4.2 JAPAN 289
10.4.2.1 Advancements in healthcare infrastructure to support market growth 289
TABLE 334 JAPAN: 3D BIOPRINTING MARKET, BY COMPONENT, 2022-2029 (USD MILLION) 289
TABLE 335 JAPAN: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022-2029 (USD MILLION) 290
TABLE 336 JAPAN: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022-2029 (USD MILLION) 290
TABLE 337 JAPAN: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2029 (USD MILLION) 291
TABLE 338 JAPAN: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 291
TABLE 339 JAPAN: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 292
TABLE 340 JAPAN: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 292
TABLE 341 JAPAN: 3D BIOPRINTING MARKET, BY END USER, 2022-2029 (USD MILLION) 293
10.4.3 INDIA 293
10.4.3.1 Increasing developments in biopharmaceutical industry to propel market growth 293
TABLE 342 INDIA: 3D BIOPRINTING MARKET, BY COMPONENT, 2022-2029 (USD MILLION) 294
TABLE 343 INDIA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022-2029 (USD MILLION) 294
TABLE 344 INDIA: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022-2029 (USD MILLION) 295
TABLE 345 INDIA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2029 (USD MILLION) 295
TABLE 346 INDIA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 296
TABLE 347 INDIA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 296
TABLE 348 INDIA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 297
TABLE 349 INDIA: 3D BIOPRINTING MARKET, BY END USER, 2022-2029 (USD MILLION) 297
10.4.4 AUSTRALIA 298
10.4.4.1 Rising private and public funding for research activities to drive market 298
TABLE 350 AUSTRALIA: 3D BIOPRINTING MARKET, BY COMPONENT, 2022-2029 (USD MILLION) 298
TABLE 351 AUSTRALIA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022-2029 (USD MILLION) 299
TABLE 352 AUSTRALIA: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022-2029 (USD MILLION) 299
TABLE 353 AUSTRALIA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2029 (USD MILLION) 300
TABLE 354 AUSTRALIA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 300
TABLE 355 AUSTRALIA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 301
TABLE 356 AUSTRALIA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 301
TABLE 357 AUSTRALIA: 3D BIOPRINTING MARKET, BY END USER, 2022-2029 (USD MILLION) 302
10.4.5 SOUTH KOREA 302
10.4.5.1 Favorable government policies and high investments from private sector to fuel market growth 302
TABLE 358 SOUTH KOREA: 3D BIOPRINTING MARKET, BY COMPONENT, 2022-2029 (USD MILLION) 303
TABLE 359 SOUTH KOREA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022-2029 (USD MILLION) 303
TABLE 360 SOUTH KOREA: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022-2029 (USD MILLION) 304
TABLE 361 SOUTH KOREA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2029 (USD MILLION) 304
TABLE 362 SOUTH KOREA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 305
TABLE 363 SOUTH KOREA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 305
TABLE 364 SOUTH KOREA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 306
TABLE 365 SOUTH KOREA: 3D BIOPRINTING MARKET, BY END USER, 2022-2029 (USD MILLION) 306
10.4.6 REST OF ASIA PACIFIC 307
10.4.7 ASIA PACIFIC: RECESSION IMPACT 307
TABLE 366 REST OF ASIA PACIFIC: 3D BIOPRINTING MARKET, BY COMPONENT, 2022-2029 (USD MILLION) 308
TABLE 367 REST OF ASIA PACIFIC: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022-2029 (USD MILLION) 308
TABLE 368 REST OF ASIA PACIFIC: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022-2029 (USD MILLION) 309
TABLE 369 REST OF ASIA PACIFIC: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2029 (USD MILLION) 309
TABLE 370 REST OF ASIA PACIFIC: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 310
TABLE 371 REST OF ASIA PACIFIC: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 310
TABLE 372 REST OF ASIA PACIFIC: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 311
TABLE 373 REST OF ASIA PACIFIC: 3D BIOPRINTING MARKET, BY END USER, 2022-2029 (USD MILLION) 311
10.5 LATIN AMERICA 312
TABLE 374 LATIN AMERICA: 3D BIOPRINTING MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 312
TABLE 375 LATIN AMERICA: 3D BIOPRINTING MARKET, BY COMPONENT, 2022-2029 (USD MILLION) 312
TABLE 376 LATIN AMERICA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022-2029 (USD MILLION) 313
TABLE 377 LATIN AMERICA: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022-2029 (USD MILLION) 313
TABLE 378 LATIN AMERICA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2029 (USD MILLION) 314
TABLE 379 LATIN AMERICA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 314
TABLE 380 LATIN AMERICA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 315
TABLE 381 LATIN AMERICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 315
TABLE 382 LATIN AMERICA: 3D BIOPRINTING MARKET, BY END USER, 2022-2029 (USD MILLION) 316
10.5.1 LATIN AMERICA: RECESSION IMPACT 316
10.5.2 BRAZIL 317
10.5.2.1 Brazil to hold largest share in Latin American market 317
TABLE 383 BRAZIL: 3D BIOPRINTING MARKET, BY COMPONENT, 2022-2029 (USD MILLION) 317
TABLE 384 BRAZIL: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022-2029 (USD MILLION) 318
TABLE 385 BRAZIL: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022-2029 (USD MILLION) 318
TABLE 386 BRAZIL: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2029 (USD MILLION) 319
TABLE 387 BRAZIL: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 319
TABLE 388 BRAZIL: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 320
TABLE 389 BRAZIL: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 320
TABLE 390 BRAZIL: 3D BIOPRINTING MARKET, BY END USER, 2022-2029 (USD MILLION) 321
10.5.3 MEXICO 321
10.5.3.1 Increasing incidence of diabetes and growing geriatric population to aid market growth 321
TABLE 391 MEXICO: 3D BIOPRINTING MARKET, BY COMPONENT, 2022-2029 (USD MILLION) 322
TABLE 392 MEXICO: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022-2029 (USD MILLION) 322
TABLE 393 MEXICO: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022-2029 (USD MILLION) 323
TABLE 394 MEXICO: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2029 (USD MILLION) 323
TABLE 395 MEXICO: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 324
TABLE 396 MEXICO: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 324
TABLE 397 MEXICO: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 325
TABLE 398 MEXICO: 3D BIOPRINTING MARKET, BY END USER, 2022-2029 (USD MILLION) 325
10.5.4 REST OF LATIN AMERICA 326
TABLE 399 REST OF LATIN AMERICA: 3D BIOPRINTING MARKET, BY COMPONENT, 2022-2029 (USD MILLION) 326
TABLE 400 REST OF LATIN AMERICA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022-2029 (USD MILLION) 327
TABLE 401 REST OF LATIN AMERICA: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022-2029 (USD MILLION) 327
TABLE 402 REST OF LATIN AMERICA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2029 (USD MILLION) 328
TABLE 403 REST OF LATIN AMERICA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 328
TABLE 404 REST OF LATIN AMERICA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 329
TABLE 405 REST OF LATIN AMERICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 329
TABLE 406 REST OF LATIN AMERICA: 3D BIOPRINTING MARKET, BY END USER, 2022-2029 (USD MILLION) 330
10.6 MIDDLE EAST 330
TABLE 407 MIDDLE EAST: 3D BIOPRINTING MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 330
TABLE 408 MIDDLE EAST: 3D BIOPRINTING MARKET, BY COMPONENT, 2022-2029 (USD MILLION) 331
TABLE 409 MIDDLE EAST: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022-2029 (USD MILLION) 331
TABLE 410 MIDDLE EAST: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022-2029 (USD MILLION) 332
TABLE 411 MIDDLE EAST: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2029 (USD MILLION) 332
TABLE 412 MIDDLE EAST: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 333
TABLE 413 MIDDLE EAST: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 333
TABLE 414 MIDDLE EAST: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 334
TABLE 415 MIDDLE EAST: 3D BIOPRINTING MARKET, BY END USER, 2022-2029 (USD MILLION) 334
10.6.1 MIDDLE EAST: RECESSION IMPACT 334
10.6.2 GCC COUNTRIES 335
TABLE 416 GCC COUNTRIES: 3D BIOPRINTING MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 335
TABLE 417 GCC COUNTRIES: 3D BIOPRINTING MARKET, BY COMPONENT, 2022-2029 (USD MILLION) 335
TABLE 418 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022-2029 (USD MILLION) 336
TABLE 419 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022-2029 (USD MILLION) 336
TABLE 420 GCC COUNTRIES: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2029 (USD MILLION) 337
TABLE 421 GCC COUNTRIES: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 337
TABLE 422 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 338
TABLE 423 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 338
TABLE 424 GCC COUNTRIES: 3D BIOPRINTING MARKET, BY END USER, 2022-2029 (USD MILLION) 339
10.6.2.1 Saudi Arabia 339
10.6.2.1.1 Increasing government investments in healthcare and growing pharmaceuticals industry to support market growth 339
TABLE 425 SAUDI ARABIA: 3D BIOPRINTING MARKET, BY COMPONENT, 2022-2029 (USD MILLION) 340
TABLE 426 SAUDI ARABIA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022-2029 (USD MILLION) 340
TABLE 427 SAUDI ARABIA: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022-2029 (USD MILLION) 341
TABLE 428 SAUDI ARABIA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2029 (USD MILLION) 341
TABLE 429 SAUDI ARABIA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 342
TABLE 430 SAUDI ARABIA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 342
TABLE 431 SAUDI ARABIA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 343
TABLE 432 SAUDI ARABIA: 3D BIOPRINTING MARKET, BY END USER, 2022-2029 (USD MILLION) 343
10.6.2.2 United Arab Emirates 344
10.6.2.2.1 Increased R&D expenditure and advanced healthcare infrastructure to boost market growth 344
TABLE 433 UNITED ARAB EMIRATES: 3D BIOPRINTING MARKET, BY COMPONENT, 2022-2029 (USD MILLION) 344
TABLE 434 UNITED ARAB EMIRATES: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022-2029 (USD MILLION) 345
TABLE 435 UNITED ARAB EMIRATES: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022-2029 (USD MILLION) 345
TABLE 436 UNITED ARAB EMIRATES: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2029 (USD MILLION) 346
TABLE 437 UNITED ARAB EMIRATES: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 346
TABLE 438 UNITED ARAB EMIRATES: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 347
TABLE 439 UNITED ARAB EMIRATES: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 347
TABLE 440 UNITED ARAB EMIRATES: 3D BIOPRINTING MARKET, BY END USER, 2022-2029 (USD MILLION) 348
10.6.2.3 Rest of GCC countries 348
TABLE 441 REST OF GCC COUNTRIES: 3D BIOPRINTING MARKET, BY COMPONENT, 2022-2029 (USD MILLION) 349
TABLE 442 REST OF GCC COUNTRIES: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022-2029 (USD MILLION) 349
TABLE 443 REST OF GCC COUNTRIES: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022-2029 (USD MILLION) 350
TABLE 444 REST OF GCC COUNTRIES: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2029 (USD MILLION) 350
TABLE 445 REST OF GCC COUNTRIES: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 351
TABLE 446 REST OF GCC COUNTRIES: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 351
TABLE 447 REST OF GCC COUNTRIES: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 352
TABLE 448 REST OF GCC COUNTRIES: 3D BIOPRINTING MARKET, BY END USER, 2022-2029 (USD MILLION) 352
10.6.3 REST OF MIDDLE EAST 353
TABLE 449 REST OF MIDDLE EAST: 3D BIOPRINTING MARKET, BY COMPONENT, 2022-2029 (USD MILLION) 353
TABLE 450 REST OF MIDDLE EAST: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022-2029 (USD MILLION) 354
TABLE 451 REST OF MIDDLE EAST: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022-2029 (USD MILLION) 354
TABLE 452 REST OF MIDDLE EAST: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2029 (USD MILLION) 355
TABLE 453 REST OF MIDDLE EAST: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 355
TABLE 454 REST OF MIDDLE EAST: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 356
TABLE 455 REST OF MIDDLE EAST: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 356
TABLE 456 REST OF MIDDLE EAST: 3D BIOPRINTING MARKET, BY END USER, 2022-2029 (USD MILLION) 357
10.7 AFRICA 357
10.7.1 GROWING FOCUS ON FUNDING AND PARTNERSHIPS IN RESEARCH SECTOR TO AID MARKET GROWTH 357
TABLE 457 AFRICA: 3D BIOPRINTING MARKET, BY COMPONENT, 2022-2029 (USD MILLION) 358
TABLE 458 AFRICA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022-2029 (USD MILLION) 358
TABLE 459 AFRICA: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022-2029 (USD MILLION) 359
TABLE 460 AFRICA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2029 (USD MILLION) 359
TABLE 461 AFRICA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 360
TABLE 462 AFRICA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 360
TABLE 463 AFRICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION) 361
TABLE 464 AFRICA: 3D BIOPRINTING MARKET, BY END USER, 2022-2029 (USD MILLION) 361
10.7.2 AFRICA: RECESSION IMPACT 361
11 COMPETITIVE LANDSCAPE 362
11.1 INTRODUCTION 362
11.2 KEY STRATEGIES/RIGHT TO WIN 362
FIGURE 33 3D BIOPRINTING MARKET: STRATEGIES ADOPTED 362
11.3 REVENUE ANALYSIS 363
FIGURE 34 REVENUE ANALYSIS OF KEY PLAYERS (2021-2023) 363
11.4 MARKET SHARE ANALYSIS 364
FIGURE 35 MARKET SHARE ANALYSIS OF KEY PLAYERS (2023) 364
TABLE 465 3D BIOPRINTING MARKET: DEGREE OF COMPETITION 365
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 366
11.5.1 STARS 366
11.5.2 EMERGING LEADERS 366
11.5.3 PERVASIVE PLAYERS 366
11.5.4 PARTICIPANTS 367
FIGURE 36 3D BIOPRINTING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 367
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 368
11.5.5.1 Overall footprint 368
FIGURE 37 3D BIOPRINTING MARKET: OVERALL FOOTPRINT 368
11.5.5.2 Component footprint 369
TABLE 466 3D BIOPRINTING MARKET: COMPONENT FOOTPRINT 369
11.5.5.3 Regional footprint 369
TABLE 467 3D BIOPRINTING MARKET: REGIONAL FOOTPRINT 369
11.5.5.4 Material footprint 370
TABLE 468 3D BIOPRINTING MARKET: MATERIAL FOOTPRINT 370
11.5.5.5 Application footprint 371
TABLE 469 3D BIOPRINTING MARKET: APPLICATION FOOTPRINT 371
11.6 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2023 371
11.6.1 PROGRESSIVE COMPANIES 371
11.6.2 RESPONSIVE COMPANIES 371
11.6.3 DYNAMIC COMPANIES 372
11.6.4 STARTING BLOCKS 372
FIGURE 38 3D BIOPRINTING MARKET: COMPANY EVALUATION MATRIX (START-UPS/SMES), 2023 372
11.6.5 COMPETITIVE BENCHMARKING: START-UPS/SMES, 2023 373
TABLE 470 3D BIOPRINTING MARKET: DETAILED LIST OF KEY START-UPS/SMES 373
TABLE 471 3D BIOPRINTING MARKET: COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES 374
11.7 VALUATION AND FINANCIAL METRICS 375
FIGURE 39 EV/EBITDA OF KEY VENDORS 375
FIGURE 40 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 375
11.8 BRAND/PRODUCT COMPARISON 376
FIGURE 41 3D BIOPRINTING MARKET: BRAND/PRODUCT COMPARISON 376
11.8.1 BICO GROUP AB 377
11.8.2 REGENHU 377
11.8.3 ROKIT HEALTHCARE, INC. 377
11.9 COMPETITIVE SCENARIO 377
11.9.1 PRODUCT LAUNCHES 377
TABLE 472 3D BIOPRINTING MARKET: PRODUCT LAUNCHES, JANUARY 2021-MARCH 2024 377
11.9.2 DEALS 378
TABLE 473 3D BIOPRINTING MARKET: DEALS, JANUARY 2021-MARCH 2024 378
11.9.3 EXPANSIONS 379
TABLE 474 3D BIOPRINTING MARKET: EXPANSIONS, JANUARY 2021-MARCH 2024 379
11.9.4 OTHER DEVELOPMENTS 379
TABLE 475 3D BIOPRINTING MARKET: OTHER DEVELOPMENTS, JANUARY 2021-MARCH 2024 379
12 COMPANY PROFILES 380
(Business overview, Products/Solutions/Services offered, Recent developments & MnM View)*
12.1 KEY PLAYERS 380
12.1.1 BICO GROUP AB 380
TABLE 476 BICO GROUP AB: COMPANY OVERVIEW 380
FIGURE 42 BICO GROUP AB: COMPANY SNAPSHOT (2023) 381
TABLE 477 BICO GROUP AB: PRODUCTS/SERVICES/SOLUTIONS OFFERED 382
TABLE 478 BICO GROUP AB: PRODUCT LAUNCHES 389
TABLE 479 BICO GROUP AB: DEALS 390
TABLE 480 BICO GROUP AB: EXPANSIONS 392
TABLE 481 BICO GROUP AB: OTHER DEVELOPMENTS 392
12.1.2 3D SYSTEMS, INC. 393
TABLE 482 3D SYSTEMS, INC.: COMPANY OVERVIEW 393
FIGURE 43 3D SYSTEMS, INC.: COMPANY SNAPSHOT (2022) 394
TABLE 483 3D SYSTEMS, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 395
TABLE 484 3D SYSTEMS, INC.: DEALS 401
TABLE 485 3D SYSTEMS, INC.: EXPANSIONS 401
12.1.3 MERCK KGAA 403
TABLE 486 MERCK KGAA: COMPANY OVERVIEW 403
FIGURE 44 MERCK KGAA: COMPANY SNAPSHOT (2023) 404
TABLE 487 MERCK KGAA: PRODUCTS/SERVICES/SOLUTIONS OFFERED 405
TABLE 488 MERCK KGAA: EXPANSIONS 409
12.1.4 ORGANOVO HOLDINGS INC. 410
TABLE 489 ORGANOVO HOLDINGS INC.: COMPANY OVERVIEW 410
FIGURE 45 ORGANOVO HOLDINGS INC.: COMPANY SNAPSHOT (2023) 411
TABLE 490 ORGANOVO HOLDINGS INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 411
TABLE 491 ORGANOVO HOLDINGS INC.: DEALS 412
12.1.5 COLLPLANT BIOTECHNOLOGIES LTD. 413
TABLE 492 COLLPLANT BIOTECHNOLOGIES LTD.: COMPANY OVERVIEW 413
FIGURE 46 COLLPLANT BIOTECHNOLOGIES LTD.: COMPANY SNAPSHOT (2023) 414
TABLE 493 COLLPLANT BIOTECHNOLOGIES LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 414
TABLE 494 COLLPLANT BIOTECHNOLOGIES LTD.: PIPELINE PRODUCTS/SERVICES/SOLUTIONS OFFERED 415
TABLE 495 COLLPLANT BIOTECHNOLOGIES LTD.: PRODUCT LAUNCHES 415
TABLE 496 COLLPLANT BIOTECHNOLOGIES LTD.: DEALS 416
12.1.6 REGENHU 417
TABLE 497 REGENHU: COMPANY OVERVIEW 417
TABLE 498 REGENHU: PRODUCTS/SERVICES/SOLUTIONS OFFERED 418
12.1.7 ASPECT BIOSYSTEMS LTD. 419
TABLE 499 ASPECT BIOSYSTEMS LTD.: COMPANY OVERVIEW 419
TABLE 500 ASPECT BIOSYSTEMS LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 419
TABLE 501 ASPECT BIOSYSTEMS LTD.: DEALS 420
12.1.8 ADVANCED SOLUTIONS LIFE SCIENCES, LLC 421
TABLE 502 ADVANCED SOLUTIONS LIFE SCIENCES, LLC: COMPANY OVERVIEW 421
TABLE 503 ADVANCED SOLUTIONS LIFE SCIENCES, LLC: PRODUCTS/SERVICES/SOLUTIONS OFFERED 421
TABLE 504 ADVANCED SOLUTIONS LIFE SCIENCES, LLC: DEALS 423
TABLE 505 ADVANCED SOLUTIONS LIFE SCIENCES, LLC: OTHER DEVELOPMENTS 423
12.1.9 CYFUSE BIOMEDICAL K.K. 424
TABLE 506 CYFUSE BIOMEDICAL K.K.: COMPANY OVERVIEW 424
TABLE 507 CYFUSE BIOMEDICAL K.K.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 424
12.1.10 ROKIT HEALTHCARE, INC. 425
TABLE 508 ROKIT HEALTHCARE, INC.: COMPANY OVERVIEW 425
TABLE 509 ROKIT HEALTHCARE, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 426
12.1.11 HANGZHOU GENOFEI BIOTECHNOLOGY CO., LTD. 427
TABLE 510 HANGZHOU GENOFEI BIOTECHNOLOGY CO., LTD.: COMPANY OVERVIEW 427
TABLE 511 HANGZHOU GENOFEI BIOTECHNOLOGY CO., LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 427
12.1.12 FOLDINK 430
TABLE 512 FOLDINK: COMPANY OVERVIEW 430
TABLE 513 FOLDINK: PRODUCTS/SERVICES/SOLUTIONS OFFERED 430
12.1.13 BRINTER 432
TABLE 514 BRINTER: COMPANY OVERVIEW 432
TABLE 515 BRINTER: PRODUCTS/SERVICES/SOLUTIONS OFFERED 432
TABLE 516 BRINTER: DEALS 434
TABLE 517 BRINTER: EXPANSIONS 435
12.1.14 3D BIOPRINTING SOLUTIONS 436
TABLE 518 3D BIOPRINTING SOLUTIONS: COMPANY OVERVIEW 436
TABLE 519 3D BIOPRINTING SOLUTIONS: PRODUCTS/SERVICES/SOLUTIONS OFFERED 436
*Details on Business overview, Products/Solutions/Services offered, Recent developments & MnM View might not be captured in case of unlisted companies.
?
12.2 OTHER PLAYERS 437
12.2.1 REGEMAT 3D, SL 437
TABLE 520 REGEMAT 3D, SL: COMPANY OVERVIEW 437
12.2.2 ????TIS 438
TABLE 521 POIETIS: COMPANY OVERVIEW 438
12.2.3 SUNP BIOTECH 439
TABLE 522 SUNP BIOTECH: COMPANY OVERVIEW 439
12.2.4 GESIM-GESELLSCHAFT FUR SILIZIUM-MIKROSYSTEME MBH 440
TABLE 523 GESIM-GESELLSCHAFT FUR SILIZIUM-MIKROSYSTEME MBH: COMPANY OVERVIEW 440
12.2.5 MEDPRIN 441
TABLE 524 MEDPRIN: COMPANY OVERVIEW 441
12.2.6 VOXCELL BIOINNOVATION INC. 441
TABLE 525 VOXCELL BIOINNOVATION INC.: COMPANY OVERVIEW 441
12.2.7 PRODWAYS 442
TABLE 526 PRODWAYS: COMPANY OVERVIEW 442
12.2.8 INVENTIA LIFE SCIENCE PTY LTD. 442
TABLE 527 INVENTIA LIFE SCIENCE PTY LTD.: COMPANY OVERVIEW 442
12.2.9 UPNANO GMBH 443
TABLE 528 UPNANO GMBH: COMPANY OVERVIEW 443
12.2.10 UPM 444
TABLE 529 UPM: COMPANY OVERVIEW 444
12.2.11 TISSUELABS 445
TABLE 530 TISSUELABS: COMPANY OVERVIEW 445
13 APPENDIX 446
13.1 DISCUSSION GUIDE 446
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 450
13.3 CUSTOMIZATION OPTIONS 452
13.4 RELATED REPORTS 452
13.5 AUTHOR DETAILS 453
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security